Document is current
Any future updates will be listed below
-
Authors
Link, Katherine E. https://orcid.org/0000-0003-2387-0116
Schnurman, Zane
Liu, Chris
Kwon, Young Joon
Jiang, Lavender Yao https://orcid.org/0000-0003-2464-3281
Nasir-Moin, Mustafa https://orcid.org/0000-0002-0389-1852
Neifert, Sean
Alzate, Juan Diego https://orcid.org/0000-0001-5663-8722
Bernstein, Kenneth https://orcid.org/0000-0001-9484-2601
Qu, Tanxia
Chen, Viola
Yang, Eunice
Golfinos, John G.
Orringer, Daniel https://orcid.org/0000-0001-6427-8376
Kondziolka, Douglas
Oermann, Eric Karl https://orcid.org/0000-0002-1876-5963
- License Information
-
More Information
Article History
Received: 27 September 2023
Accepted: 6 September 2024
First Online: 17 September 2024
Competing interests
: The authors declare the following competing interests. E.K.O. reports consulting with Sofinnova Inc., Google Inc., income from Merck & Co., and Mirati Therapeutics, and equity in Artisight Inc. D.O. is a consultant and equity holder of Invenio Inc. D.K. reports consulting with Elekta Inc. K.E.L. is currently employed by NVIDIA. L.Y.J., M.N., S.N., J.D.A., K.B., T.Q., V.C., E.Y., and J.G.G. declare no competing interests. The work presented herein was performed exclusively within the NYU Langone Health System.
